Definium Therapeutics Us, Inc.

This study is testing whether an oral medication called MM120 can help reduce symptoms of generalized anxiety disorder (GAD). About 375 adults with moderate to severe anxiety will take either MM120 or a placebo for 12 weeks, followed by a 40-week period where everyone may receive…

This study is testing whether an oral medication called MM120 can help control symptoms of generalized anxiety disorder. It will involve 200 adults with moderate to severe anxiety who will take either the medication or a placebo for 12 weeks, followed by an optional 40-week exten…

This study is testing a single dose of an investigational medicine called MM402 in about 20 adults with autism spectrum disorder (ASD). The main goal is to see if the medicine can help improve difficulties with socializing and communication. Researchers will measure how participa…